l-hydrazinophthalazine ("Apresoline") has been shown to lower the blood pressure and augment the renal blood flow in certain hypertensive patients (1, 2) . Although the drug induces vasodilatation, its exact mechanism of action requires further study. Some evidence suggests that it may suppress the sympathetic vasoconstrictor reflexes which cause the "overshoot" in arterial pressure following the Valsalva maneuver (3) . Also it appears to have the capacity of inhibiting pressor substances of either renal (4) or cerebral (5) origin.
The present study was undertaken in order to measure the effect of this drug, given intramuscularly, on cerebral blood flow, cerebral vascular resistance, cerebral oxygen uptake and jugular venous oxygen tension of patients with essential hypertension. For comparison, other patients were given a placebo. The effects of "Apresoline" have been compared with the changes observed after the placebo and during the hypotension induced by differential spinal sympathetic block (6) , 20°head-up tilt (7) , dihydroergocornine (8) , protoveratrine (9) , and sympathectomy (10) . METHODS 1. Choice of subjects: Seven patients with essential hypertension were selected from the medical and surgical wards of the Hospital of the University of Pennsylvania for the "Apresoline" study. Two patients were in the Group I life expectancy classification of Smithwick (11) , three were in Group II and two were in Group IV (poorest prognosis). I This investigation is being supported in part by research grants from the National Heart Institute, U. S. Public Health Service (H-361), and the Ciba Pharmaceutical Products, Inc.
The placebo injection study group consisted of the following six patients: one in Group I, three in Group II and two in Group IV. Five additional patients were studied after subtotal adrenalectomy (12) (approximately 88-98 per cent) before and after the placebo. The preadrenalectomy grouping of these patients with severe hypertension and vascular complications was: one in Group II and four in Group IV. They were selected at random without regard to their postoperative blood pressure level. All patients were ambulatory and required cortisone or cortisone and desoxycorticosterone at the time of the initial postadrenalectomy study. One patient, I. B. (Table II) , was tested 3 and 12 months after operation. These patients were tested to see whether patients with adrenalectomy responded differently after the placebo injection as to mean arterial pressure, cerebral blood flow and oxygen consumption and jugular venous oxygen tension. These patients are shown below the heavy line in Table II. 2. Technique of study: Cerebral blood flow and oxygen consumption were determined in the supine position by the nitrous oxide method (13) . Mean femoral arterial pressure was measured through an indwelling femoral arterial needle. Analyses of blood gases were made by methods reported previously (13, 14) . Hydrogen ion concentration of arterial and venous blood was measured anaerobically at room temperature and corrected to 370 C. (15 (6, 16) . This estimation is assumed to vary directly with cerebral oxygen tension (17) . The (p < 0.02). (6) Vnits are as in Table I .
Signifies statistically significant reduction (p < 0.02). I. Intramuscular 1-hydrazinophthalazine in patients with essential hypertension Mean arterial pressure of this group was reduced from 144 to 113 mm. Hg approximately 60 minutes after an average dose of 14 mgms. (Table  III) . Cerebral blood flow, oxygen uptake and venous oxygen tension were unchanged. No unpleasant reactions were observed. Pulse rate increased. The data of the individual tests are presented in Table I .
II. Intravenous saline placebo
A. In patients with essential hypertension The data of the individual patients are shown in Table II . Repetition of the observations 60 minutes after the intravenous injection of saline solution showed no significant differences from the initial measurements (Table III) . There was no consistent change which could be correlated with the patient's apparent state of nervous tension. Two patients appeared to become more relaxed after the placebo. Vascular resistance increased slightly in one (E. Z., Table II ) and decreased markedly in the other (W. P., Table II). B. In patients who had undergone subtotal adrenalectomy alone or combined with sympathectomy
The individual observations are shown in Table  II and the mean changes are presented in Table  III . There were no significant changes in the cerebral functions measured in these patients one hour after the intravenous saline injection.
One patient (A. F., Table II ) was tested with the placebo injection both before and after adrenalectomy-sympathectomy. Minimal changes following the placebo were observed both before and after operation. Cerebral venous oxygen tension in this patient was markedly stable (31 to 34 mm. Hg).
I. B. was tested three months and again at twelve months after operation. A slight decrease in resistance was observed after the placebo in each study. This patient was tense during the control cerebral blood flow measurement in the early postadrenalectomy study, but not during either the control or the post-injection measurements made twelve months after adrenalectomy. Resistance decreased more after the placebo in the earlier study. Although the mean change in cerebral blood flow in this group was small and not significant, one patient, T. C. (Table II) , had a reduction of flow almost twice the standard deviation of this group. The arterial carbon dioxide tension of this patient was reduced from 46 to 41 mm. Hg as he grew more restless at the end of the 60 minutes. This may account for the reduction in cerebral blood flow (18). Table III indicate that cerebral blood flow was unchanged after "Apresoline" at a time when the arterial carbon dioxide tension was significantly reduced. The 25 per cent reduction in cerebral vascular resistance induced by the drug is all the more impressive because the reduction in arterial carbon dioxide tension would tend to increase cerebral vascular resistance (18). The data of Table III show a tendency for cerebral blood flow to decrease after the saline injection in both groups. This was not observed after 1-hydrazinophthalazine.
DISCUSSION

Mean values in
Reubi found the renal vascular resistance to be reduced 40 per cent about 45 minutes after an intravenous injection of 10 to 20 mgms. of 1-hydrazinophthalazine (1) . The mean arterial pressure of his patients was lower than that of the group we studied, and was reduced by about 15 per cent of the pre-injection level.
Comparative data have been collected on patients with essential hypertension when hypotension in the cerebral arterial system was induced by other drugs (8, 9) , sympathectomy (10), or twenty degree headup tilt for 20 minutes. The mean reduction in cerebral vascular resistance induced by l-hydrazinophthalazine appears to be the same (about 25 per cent) as that induced by dihydroergocornine and intravenous protoveratrine.
Reduction in mean cerebral blood flow was observed in patients with essential hypertension only after the extreme pressure drop of differential spinal block. The second flow measurements were made when the arterial pressure appeared to be stabilized, however, and mean oxygen uptake was unchanged. A slight increase in mean oxygen uptake was observed during the head-up tilt. In several of these studies, a reduction in the mean oxygen content of the internal jugular venous blood was observed even though the cerebral oxygen uptake was unchanged (6, 7, 10) .
Such observations raised the question as-to whether the mean decreases in cerebral venous oxygen content were associated with significant reductions in jugular venous oxygen tension (6) . This uncertainty led us to measure indirectly oxygen tension, thus defining the range of "cerebral oxygen tension" and cerebral blood flow in patients with essential hypertension under the conditions of these experiments.
The relatively close agreement of the measurements in the two groups, as indicated by both mean and individual data, is reassuring when one considers the large number of possible biological, experimental and analytical variations. These observations appear to afford a better baseline for the interpretation of real changes in future studies designed to clarify the influence of varying blood gas tensions on the increased cerebral vascular tone of patients with essential hypertension.
SUMMARY
Eight measurements of arterial and internal jugular blood gases, cerebral blood flow, oxygen uptake and venous oxygen tension were made in seven patients with mild essential hypertension before and after a reduction in mean arterial pressure induced by intramuscular 1-hydrazinophthalazine ("Apresoline").
The high cerebral vascular resistance of essential hypertension was reduced. This was associated with a slight reduction in arterial carbon dioxide tension. Cerebral blood flow, oxygen uptake and venous oxygen tension were unchanged after the drug. The data obtained in the "Apresoline" study have been compared with measurements made before and after a placebo injection in six other patients with essential hypertension. Five patients who had subtotal adrenalectomy previously were also tested. The observations after the placebo disclosed no significant differences from the initial mean values in each group. Cerebral blood flow and oxygen consumption remained constant.
The reduction in the cerebral vascular resistance of hypertensive patients after "Apresoline" was sufficient to allow cerebral blood flow and oxygen consumption to remain constant and was comparable to that observed during the hypotension induced by dihydroergocornine and protoveratrine.
